By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

After the slimming effect of Ozempic and Zepbound earned billions for Novo Nordisk and Eli Lilly, another class of ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

US telehealth group explores selling ‘compounded medications’ in new markets after buying London-based rival Zava ...

A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...

Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...

As congressional Republicans attempt to cut Medicaid spending, Democratic Gov. Katie Hobbs signed a bill that could expand ...

New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...